|
Insider Trading: Cephalon Inc
Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Cephalon Inc in the last 24 months are illustrated in figures 1 and 2. Table 1 shows the monthly insider trading data of Cephalon Inc since year 2005. Table 2 shows the detailed insider transactions of Cephalon Inc since 2005.
The reporting company's ticker symbol is CEPH.
The reporting company's CIK number is 873364.
The total value of stock buying since 2005 is $0.
The total value of stock sales is $120,643,662.
The total value of stock exercises is $43,050,229.
1 year stock price chart,
1 day stock price chart
opopp opopopop
Figure 1. Monthly insider transaction values at Cephalon Inc (CEPH) in the past 24 months.
The trade values of insider stock buys, sales, and option exercises are in logarithmic scale
as shown on the right axis labels.
The detailed monthly and daily insider transactions are listed in the 2 tables below.
09 10 11 12 01 2007 02 03 04 05 06 07 08 09 10 11 12 01 2008 02 03 04 05 06 07 08 -
Figure 2. Average prices of insider buys, sales, and option exercises at Cephalon Inc (CEPH) in the past 24 months. See table 2 for insider transaction details.
09 10 11 12 01 2007 02 03 04 05 06 07 08 09 10 11 12 01 2008 02 03 04 05 06 07 08 -
Table 1. Monthly summaries of insider stock purchases, sales, and option exercises
for Cephalon Inc (CEPH).
Trading Period
year-month |
Insider Buying
Shares Value ($) |
Insider Sales
Shares Value ($) |
Option Exercises
Shares Value ($) |
| 2008-08 | 0 | 0 | 149,162 | 11,201,704 | 131,602 | 6,199,799 |
| 2008-03 | 0 | 0 | 18,495 | 1,115,279 | 10,000 | 123,749 |
| 2007-12 | 0 | 0 | 287,831 | 22,255,699 | 185,475 | 8,524,435 |
| 2007-11 | 0 | 0 | 120,255 | 8,978,280 | 60,000 | 630,000 |
| 2007-05 | 0 | 0 | 44,184 | 3,559,381 | 42,625 | 1,951,758 |
| 2007-02 | 0 | 0 | 105,655 | 7,963,656 | 112,074 | 5,345,716 |
| 2006-12 | 0 | 0 | 36,411 | 2,531,673 | 0 | 0 |
| 2006-09 | 0 | 0 | 5,000 | 290,083 | 5,000 | 64,375 |
| 2006-03 | 0 | 0 | 196,000 | 15,722,135 | 139,500 | 6,921,342 |
| 2006-02 | 0 | 0 | 603,291 | 45,561,734 | 394,923 | 13,289,055 |
| 2005-09 | 0 | 0 | 2,500 | 114,412 | 0 | 0 |
| 2005-05 | 0 | 0 | 30,373 | 1,349,626 | 0 | 0 |
Table 2. Detailed insider stock purchases, sales, and option exercises
for Cephalon Inc (CEPH)
| Trade Date |
Insider Name |
Trade Type |
Shares |
Price ($) |
Value ($) |
| 2008-08-11 | Russell Lesley (Exec. VP, WW Med & Reg Affairs) | Sale | 27,000 | 77.23 | 2,085,210 |
| 2008-08-11 | Russell Lesley (Exec. VP, WW Med & Reg Affairs) | Option Exercise | 27,000 | 54.84 | 1,480,545 |
| 2008-08-11 | Roche Robert P Jr (Exec. VP, WW Pharm Ops) | Sale | 21,676 | 76.96 | 1,668,184 |
| 2008-08-11 | Roche Robert P Jr (Exec. VP, WW Pharm Ops) | Option Exercise | 21,676 | 49.11 | 1,064,580 |
| 2008-08-07 | Vaught Jeffry L (Exec. VP, R&D) | Sale | 17,560 | 76.44 | 1,342,286 |
| 2008-08-04 | Grebow Peter E (Exec. VP, WW Technical Ops.) | Sale | 62,926 | 73.59 | 4,630,724 |
| 2008-08-04 | Grebow Peter E (Exec. VP, WW Technical Ops.) | Option Exercise | 62,926 | 49.11 | 3,090,505 |
| 2008-08-04 | Wilensky Gail R (Director) | Sale | 10,000 | 73.51 | 735,100 |
| 2008-08-04 | Wilensky Gail R (Director) | Option Exercise | 10,000 | 45.23 | 452,299 |
| 2008-08-01 | Greenacre Martyn D (Director) | Sale | 10,000 | 74.02 | 740,200 |
| 2008-08-01 | Greenacre Martyn D (Director) | Option Exercise | 10,000 | 11.19 | 111,870 |
| 2008-03-07 | Egan William P (Director) | Sale | 8,895 | 60.32 | 535,817 |
| 2008-03-07 | Egan William P (Director) | Option Exercise | 8,895 | 12.38 | 110,075 |
| 2008-03-06 | Egan William P (Director) | Sale | 1,105 | 61.36 | 67,805 |
| 2008-03-06 | Egan William P (Director) | Option Exercise | 1,105 | 12.38 | 13,674 |
| 2007-12-21 | Roche Robert P Jr (Exec. VP, WW Pharm Ops.) | Sale | 7,185 | 72.62 | 521,750 |
| 2007-12-12 | Roche Robert P Jr (Exec VP, WW Pharmaceutical Ops) | Sale | 34,176 | 75.94 | 2,593,105 |
| 2007-12-12 | Roche Robert P Jr (Exec VP, WW Pharmaceutical Ops) | Option Exercise | 34,176 | 49.63 | 1,696,069 |
| 2007-12-10 | Roche Robert P Jr (Exec VP, WW Pharmaceutical Ops) | Sale | 1,347 | 78.56 | 105,814 |
| 2007-12-10 | Roche Robert P Jr (Exec VP, WW Pharmaceutical Ops) | Option Exercise | 2,074 | 48.20 | 99,966 |
| 2007-12-10 | Savini Carl A (Exec. VP & CAO) | Sale | 61,043 | 78.67 | 4,801,108 |
| 2007-12-10 | Savini Carl A (Exec. VP & CAO) | Option Exercise | 50,125 | 49.63 | 2,487,578 |
| 2007-12-06 | Russell Lesley (Exec. VP, WW Med & Reg Affairs) | Sale | 24,100 | 77.00 | 1,855,700 |
| 2007-12-06 | Russell Lesley (Exec. VP, WW Med & Reg Affairs) | Option Exercise | 24,100 | 47.61 | 1,147,481 |
| 2007-12-06 | Buchi J Kevin (Exec. Vice President & CFO) | Sale | 20,000 | 76.00 | 1,520,068 |
| 2007-12-06 | Vaught Jeffry L (Exec. VP & Pres., R&D) | Sale | 70,000 | 77.07 | 5,394,792 |
| 2007-12-06 | Vaught Jeffry L (Exec. VP & Pres., R&D) | Option Exercise | 70,000 | 43.31 | 3,031,466 |
| 2007-12-03 | Greenacre Martyn D (Director) | Sale | 5,000 | 74.86 | 374,325 |
| 2007-12-03 | Greenacre Martyn D (Director) | Option Exercise | 5,000 | 12.38 | 61,875 |
| 2007-11-29 | Grebow Peter E (Exec. VP, WW Technical Ops.) | Sale | 11,639 | 74.80 | 870,597 |
| 2007-11-28 | Roche Robert P Jr (Exec VP, WW Pharmaceutical Ops) | Sale | 5,255 | 75.35 | 395,945 |
| 2007-11-19 | Baldino Frank Jr (Chairman & CEO) | Sale | 52,552 | 74.83 | 3,921,282 |
| 2007-11-19 | Baldino Frank Jr (Chairman & CEO) | Option Exercise | 60,000 | 10.50 | 630,000 |
| 2007-05-30 | Greenacre Martyn D (Director) | Sale | 5,000 | 81.43 | 407,150 |
| 2007-05-30 | Greenacre Martyn D (Director) | Option Exercise | 5,000 | 12.38 | 61,875 |
| 2007-05-25 | Osborn John E (Exec VP, General Counsel & Sec) | Sale | 26,375 | 80.24 | 2,116,254 |
| 2007-05-25 | Osborn John E (Exec VP, General Counsel & Sec) | Option Exercise | 26,375 | 51.12 | 1,348,421 |
| 2007-05-09 | Russell Lesley (Exec. VP, WW Med & Reg Affairs) | Sale | 1,559 | 80.00 | 124,727 |
| 2007-05-07 | Osborn John E (Exec VP, General Counsel & Sec) | Sale | 11,250 | 81.00 | 911,250 |
| 2007-05-07 | Osborn John E (Exec VP, General Counsel & Sec) | Option Exercise | 11,250 | 48.13 | 541,462 |
| 2007-02-20 | Grebow Peter E (Exec VP,Worldwide Tech Ops.) | Sale | 6,000 | 74.27 | 445,620 |
| 2007-02-16 | Grebow Peter E (Exec VP,Worldwide Tech Ops.) | Sale | 50,000 | 75.37 | 3,772,384 |
| 2007-02-16 | Grebow Peter E (Exec VP,Worldwide Tech Ops.) | Option Exercise | 52,074 | 49.68 | 2,658,466 |
| 2007-02-16 | Egan William P (Director) | Sale | 10,000 | 75.15 | 751,522 |
| 2007-02-16 | Egan William P (Director) | Option Exercise | 10,000 | 12.88 | 128,750 |
| 2006-12-22 | Roche Robert P Jr (Exec VP, Worldwide Pharm Ops.) | Sale | 3,385 | 69.75 | 236,103 |
| 2006-12-22 | Baldino Frank Jr (Chairman & CEO) | Sale | 20,000 | 69.25 | 1,385,000 |
| 2006-12-21 | Roche Robert P Jr (Exec VP, Worldwide Pharm Ops.) | Sale | 5,000 | 69.75 | 348,750 |
| 2006-12-21 | Osborn John E (Exec. VP & General Counsel) | Sale | 8,026 | 70.00 | 561,820 |
| 2006-09-05 | Greenacre Martyn D (Director) | Sale | 5,000 | 58.02 | 290,083 |
| 2006-09-05 | Greenacre Martyn D (Director) | Option Exercise | 5,000 | 12.88 | 64,375 |
| 2006-03-01 | Roche Robert P Jr (Exec VP, Worldwide Pharm Ops.) | Sale | 80,500 | 80.23 | 6,458,136 |
| 2006-03-01 | Roche Robert P Jr (Exec VP, Worldwide Pharm Ops.) | Option Exercise | 80,500 | 50.13 | 4,035,800 |
| 2006-03-01 | Savini Carl A (Exec VP & Chief Admin Officer) | Sale | 59,000 | 80.22 | 4,732,287 |
| 2006-03-01 | Savini Carl A (Exec VP & Chief Admin Officer) | Option Exercise | 59,000 | 48.91 | 2,885,542 |
| 2006-02-27 | Baldino Frank Jr (Chairman & CEO) | Sale | 103,098 | 80.45 | 8,294,273 |
| 2006-02-27 | Baldino Frank Jr (Chairman & CEO) | Option Exercise | 50,000 | 17.75 | 887,500 |
| 2006-02-24 | Grebow Peter E (Exec VP,Worldwide Tech Ops.) | Sale | 45,000 | 76.58 | 3,446,204 |
| 2006-02-24 | Grebow Peter E (Exec VP,Worldwide Tech Ops.) | Option Exercise | 35,000 | 43.29 | 1,515,208 |
| 2006-02-21 | Witzel Horst (Director) | Sale | 60,000 | 74.12 | 4,447,457 |
| 2006-02-21 | Witzel Horst (Director) | Option Exercise | 60,000 | 54.29 | 3,257,200 |
| 2006-02-21 | Osborn John E (Sr. VP, General Counsel & Sec.) | Sale | 41,625 | 73.98 | 3,083,379 |
| 2006-02-21 | Osborn John E (Sr. VP, General Counsel & Sec.) | Option Exercise | 41,625 | 51.17 | 2,129,951 |
| 2006-02-21 | Egan William P (Director) | Sale | 10,000 | 74.01 | 740,055 |
| 2006-02-17 | Roche Robert P Jr (Exec VP, Worldwide Pharm Ops.) | Sale | 30,550 | 74.09 | 2,263,449 |
| 2006-02-17 | Roche Robert P Jr (Exec VP, Worldwide Pharm Ops.) | Option Exercise | 23,700 | 15.33 | 363,399 |
| 2006-02-17 | Greenacre Martyn D (Director) | Sale | 15,000 | 74.45 | 1,116,685 |
| 2006-02-17 | Greenacre Martyn D (Director) | Option Exercise | 15,000 | 21.69 | 325,312 |
| 2006-02-17 | Buchi J Kevin (Sr. Vice President and CFO) | Sale | 29,073 | 74.40 | 2,163,127 |
| 2006-02-17 | Buchi J Kevin (Sr. Vice President and CFO) | Option Exercise | 29,073 | 15.33 | 445,785 |
| 2006-02-17 | Grebow Peter E (Exec VP,Worldwide Tech Ops.) | Sale | 10,000 | 73.33 | 733,340 |
| 2006-02-17 | Grebow Peter E (Exec VP,Worldwide Tech Ops.) | Option Exercise | 6,000 | 17.75 | 106,500 |
| 2006-02-17 | Savini Carl A (Sr VP & Chief Admin Officer) | Sale | 49,185 | 73.93 | 3,636,082 |
| 2006-02-17 | Savini Carl A (Sr VP & Chief Admin Officer) | Option Exercise | 39,125 | 29.12 | 1,139,515 |
| 2006-02-17 | Osborn John E (Sr. VP, General Counsel & Sec.) | Sale | 52,318 | 73.86 | 3,869,683 |
| 2006-02-17 | Osborn John E (Sr. VP, General Counsel & Sec.) | Option Exercise | 47,500 | 49.63 | 2,357,306 |
| 2006-02-17 | Vaught Jeffry L (Sr. Vice Pres., and Pres., R&D) | Sale | 37,900 | 74.44 | 2,821,444 |
| 2006-02-17 | Vaught Jeffry L (Sr. Vice Pres., and Pres., R&D) | Option Exercise | 37,900 | 12.04 | 456,379 |
| 2006-02-17 | Blake Paul (Exec VP, Clin Res & Reg Aff) | Sale | 6,938 | 74.53 | 517,075 |
| 2006-02-17 | Egan William P (Director) | Option Exercise | 10,000 | 30.50 | 305,000 |
| 2005-09-19 | Roche Robert P Jr (Exec VP, Worldwide P) | Sale | 2,500 | 45.76 | 114,412 |
| 2005-05-17 | Baldino Frank Jr (CEO) | Sale | 25,373 | 44.23 | 1,122,146 |
| 2005-05-09 | Egan William P (Director) | Sale | 5,000 | 45.50 | 227,480 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above tables cannot be completely guaranteed as to their accuracy.
For more insider trading information of Cephalon Inc (symbol CEPH,
CIK number 873364) see
the Securities and Exchange Commission (SEC) website.
|
|
